KCNQ5 Gene <table class="infobox infobox-gene">
...
KCNQ5 Gene <table class="infobox infobox-gene">
Overview KCNQ5 (Potassium Voltage-Gated Channel Subfamily Q Member 5) encodes the Kv7.5 potassium channel, a voltage-gated potassium channel expressed predominantly in the brain and muscle tissue. Like other KCNQ channels (KCNQ1-5), KCNQ5 generates the M-current, a slowly activating potassium current that plays a critical role in regulating neuronal excitability, action potential threshold, and firing frequency[@schroeder2000][@jentsch2000].
The M-current was first described as a target of muscarinic acetylcholine receptor modulation, and KCNQ channels (also called Kv7 channels) are the molecular substrates for this important regulatory pathway.
Gene and Protein Structure
The KCNQ5 gene produces multiple isoforms through alternative splicing:
Full-length KCNQ5 (KCNQ5-1) : Complete protein with all functional domainsKCNQ5-2 : Shorter isoform missing N-terminal regulatory regionsKCNQ5-3 : Brain-specific isoform with distinct expression patternsProtein Domain Architecture N-terminus [A domain] --- [S1-S6 transmembrane domain] --- [C-terminus]
A domain (Activation) : N-terminal domain involved in channel activationS1-S6 transmembrane segments : Six transmembrane helices forming the voltage sensor and poreS4 voltage sensor : Positively charged residues that respond to membrane potentialPore loop : Forms the potassium selectivity filterC-terminal domain : Contains binding sites for PIP2 and calmodulinBiological Functions
M-Current Generation The KCNQ5 channel generates the slowly activating M-current in neurons[@gamper2005]:
Voltage-dependent activation : Activates slowly upon depolarization (10-50 mV/s)Muscarinic modulation : Inhibited by M1/M3 muscarinic acetylcholine receptor activationPersistent sodium current suppression : KCNQ5 limits persistent Na+ currentsRepolarization assistance : Helps repolarize neurons after action potentialsExcitability regulation : Controls firing threshold and frequency
Channel Regulation KCNQ5 channels are subject to multiple regulatory mechanisms[@gamper2005]:
PIP2 requirement : Phosphatidylinositol 4,5-bisphosphate (PIP2) is essential for channel activityCalmodulin binding : Calcium/calmodulin modulates channel functionPhosphorylation : PKC and other kinases can modulate channel activityAlternative splicing : Different isoforms have distinct regulatory propertiesHeteromeric Assembly KCNQ5 can form heteromeric channels:
KCNQ3/KCNQ5 : Major brain heteromer with distinct propertiesKCNQ4/KCNQ5 : Expressed in inner ear and some neuronsHomomeric KCNQ5 : Functional channels in some neuronal populationsExpression Pattern
Brain Distribution KCNQ5 shows distinct regional expression in the brain[@petrzlikova2015]:
Cortex : High expression in layer 5 pyramidal neuronsHippocampus : Present in CA1-CA3 pyramidal cellsBasal ganglia : High expression in striatum and substantia nigraCerebellum : Expressed in Purkinje cells and granule cellsThalamus : Moderate expression in thalamic nucleiCellular Distribution
Neurons : Primarily in excitatory neuronsAstrocytes : Low expressionOligodendrocytes : Limited expressionPeripheral tissues : Skeletal muscleRole in Neurodegeneration
Alzheimer's Disease In AD, KCNQ5 dysregulation contributes to network hyperexcitability[@chambers2016]:
M-current reduction : Altered KCNQ5 expression in AD brain regionsNetwork hyperexcitability : Loss of M-current leads to increased neuronal firingAmyloid-beta interaction : Aβ may affect KCNQ channel functionTherapeutic implications : KCNQ5 activators may reduce hyperexcitabilityParkinson's Disease KCNQ5 plays important roles in basal ganglia function[@wickenden2009]:
Striatal neuron excitability : Modulates medium spiny neuron activityDopaminergic modulation : Dopamine may modulate KCNQ channel activityMotor control : Altered KCNQ5 may contribute to motor symptomsTherapeutic potential : KCNQ modulators for motor symptomsEpilepsy and Seizures KCNQ5 mutations are associated with epileptic encephalopathy[@singh2010]:
M-current reduction : Loss-of-function mutations reduce M-currentHyperexcitability : Leads to seizure predispositionTherapeutic targeting : KCNQ activators (retigabine) have anticonvulsant effectsIntellectual Disability KCNQ5 mutations cause intellectual disability with speech and language impairments:
Synaptic plasticity : KCNQ5 modulates synaptic functionNetwork development : Critical for proper neuronal circuit formationCognitive function : Linked to learning and memoryMigraine KCNQ channels are implicated in migraine pathophysiology:
Cortical spreading depression : Involved in migraine auraNeuronal excitability : KCNQ5 modulators may prevent spreading depressionTherapeutic target : KCNQ openers under investigationTherapeutic Targeting
Channel Openers
Mechanism KCNQ channel openers work by:
Stabilizing open state : Reduce voltage dependence of activationEnhancing PIP2 affinity : Improve channel responsivenessPromoting channel trafficking : Increase surface expressionBenefits and Risks Potential benefits:
Reduces neuronal hyperexcitability
Anticonvulsant effects
May protect against neurodegeneration
Potential for motor symptoms in PD
Risks and concerns:
Central nervous system side effects
Withdrawal due to safety concerns (retigabine)
Limited selectivity
Disease Associations
Interacting Partners
See Also
[Potassium Channels](/mechanisms/potassium-channels)
[Neuronal Excitability](/mechanisms/neuronal-excitability)
[M-Current](/mechanisms/m-current)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Epilepsy](/diseases/epilepsy)
External Links
[NCBI Gene - KCNQ5](https://www.ncbi.nlm.nih.gov/gene/56479)
[UniProt - Q9NRX3](https://www.uniprot.org/uniprot/Q9NRX3)
[Ensembl - KCNQ5](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131808)
[IUPHAR - KCNQ5](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=536)
References
[Schroeder BC et al., KCNQ5 encodes a novel neuronal potassium channel. J Biol Chem (2000)](https://pubmed.ncbi.nlm.nih.gov/10658906/)
[Lerche C et al., Alternative promoter usage in the human KCNQ2 gene. Am J Physiol Cell Physiol (2000)](https://pubmed.ncbi.nlm.nih.gov/10837230/)
[Gamper N et al., Neuronal M-channel modulation by intracellular ATP and PIP2. J Neurosci (2005)](https://pubmed.ncbi.nlm.nih.gov/15716413/)
[Chambers C et al., KCNQ5 channels mediate persistent sodium current contributions to neuronal excitability. Neurobiol Dis (2016)](https://pubmed.ncbi.nlm.nih.gov/27085488/)
[Wickenden AK et al., KCNQ potassium channels in brain ischemia: a novel neuroprotective target? Prog Biophys Mol Biol (2009)](https://pubmed.ncbi.nlm.nih.gov/19103142/)
[Petrzlikova K et al., Differential expression and localization of KCNQ2 and KCNQ5 in the human brain. Brain Res (2015)](https://pubmed.ncbi.nlm.nih.gov/25882445/)
[Singh NA et al., KCNQ2 mutation in patients with benign familial neonatal seizures. Neurology (2010)](https://pubmed.ncbi.nlm.nih.gov/201009999/)
[Lehmann D et al., KCNQ channels in cardiovascular disease: a novel therapeutic target? J Mol Cell Cardiol (2008)](https://pubmed.ncbi.nlm.nih.gov/186194423/)
[Jentsch TJ., Neuronal KCNQ potassium channels: pharmacology and pathophysiology. Trends Pharmacol Sci (2000)](https://pubmed.ncbi.nlm.nih.gov/10664799/)
[Robbins J., KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther (2001)](https://pubmed.ncbi.nlm.nih.gov/11450504/)
Show full description